Zhejiang, China

Jun Dai

This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Dai. Retrieved from https://idiyas.com/inventor/jun-dai-57sgvpbe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jun Dai - Innovator in Pharmaceutical Formulations

Introduction

Jun Dai is a notable inventor based in Zhejiang, China, recognized for his contributions to the pharmaceutical industry. With a focus on drug formulations, he has made significant strides in the development of innovative tablet technologies.

Latest Patents

Jun Dai holds a patent for the HS-25 tablet and its preparation method. This invention includes an HS-25 solid dispersion composition, a preparation method, and the usage of the HS-25 tablet, which is created using HS-25 and various excipients through processes such as wet granulation, drying, granulating, and tablet pressing.

Career Highlights

Jun Dai is affiliated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical sciences. His work has contributed to the enhancement of drug delivery systems, showcasing his commitment to improving therapeutic outcomes for patients.

Collaborations

Throughout his career, Jun Dai has collaborated with talented professionals in the field, including his coworkers Li Ding and Chunrong Feng. These collaborations foster a dynamic environment for innovation and contribute to the advancement of their shared goals in pharmaceutical development.

Conclusion

Jun Dai exemplifies the spirit of innovation within the pharmaceutical industry through his patented inventions. His dedication to creating effective drug formulations continues to make a lasting impact in the field, benefitting both the industry and patients alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…